一、重组蛋白质药物技术平台五康生物的重组蛋白质药物技术平台承担蛋白质药物设计、蛋白质药物制备和药效验证等蛋白质药物研发的前期工作,该平台具有独特的技术特点,在蛋白质药物设计和改造方面具有巨大优势。新颖的蛋白疫苗设计技术如何打破人体的免疫耐受是治疗性疫苗设计核心的问题。五康生物的蛋白疫苗技术独辟蹊径设计了一类能够诱导人体产生特异性免疫反应的新型蛋白类疫苗设计技术,具有完全自主知识产权。接种这类疫苗后,人体自身会产 I. Recombinant Protein Pharmaceutical Technology Platform The recombinant protein drug technology platform of WuKang Bio-Chemical Co., Ltd. undertakes the preliminary work on protein drug development such as protein drug design, protein drug preparation and drug efficacy verification. The platform has unique technical features in protein drug design and modification Has a huge advantage. How Novel Protein Vaccine Design Techniques Break Down Your Immune Tolerance is At The Core of Therapeutic Vaccine Design. Five Kang biological protein vaccine technology unique to design a class to induce the body to produce a specific immune response of the new protein vaccine design technology, with complete independent intellectual property rights. After vaccination, the body produces itself